Cronos Group Inc vs Rockwell Automation — how do they compare? Cronos Group Inc trades at $3.22 (market cap $1.18B), while Rockwell Automation trades at $432.38 (market cap $48.21B). The key difference: Rockwell Automation is far larger — about 40.9× Cronos Group Inc's market cap, and Rockwell Automation pays a 1.27% dividend while Cronos Group Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Cronos Group Inc for 22 Days and Rockwell Automation for 74 Days on average.
| CRON | ROK | |
|---|---|---|
Market Cap | $1.18B | $48.21B |
Volume | 968,037 | 953,342 |
Sector | Health | Industrials |
52-Week High | $3.55 | $495.08 |
52-Week Low | $2.30 | $333.75 |
Typical Hold Time | 22 Days | 74 Days |
Enterprise Value | $387.62M | $51.34B |
Dividend Yield | — | 1.27% |
Signals from Pluang's Aura AI — not financial advice
CRON trades at $3.23, down 0.31% with a bearish technical signal. Recent earnings show volatility with Q2 2026 beating expectations ($0.09 vs $0.01) but Q4 2025 missing. Revenue grew from $118M (2024) to $147M (2025), though net income turned negative at -$9M. The company maintains strong liquidity with $827M cash and no debt, highlighted in recent investor day presentations.
Outlook is mixed: analyst consensus leans Hold (60%) with cautious optimism on international expansion and margin improvements. Key risks include sustained negative cash flow (-$67M in 2025) and competitive pressures. Upside hinges on execution of growth initiatives in Canada and Europe, with profitability projections for 2026.
Rockwell Automation (ROK) trades at $432.61, down 2.1% on the day, with a bearish technical signal. The stock shows strong profitability with a 13.38% net income margin and 34.47% ROE, but trades at elevated valuation multiples including a P/E of 40.65. Recent earnings have consistently beaten estimates, and the company maintains a solid cash flow profile. Positive news highlights its leadership in industrial automation and digital transformation initiatives.
The outlook is mixed: analyst consensus is a Buy with a $489.89 price target, implying potential upside, but high valuation and near-term technical weakness pose risks. Key catalysts include continued execution on automation demand trends, while risks involve macroeconomic sensitivity and competitive pressures.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.
Read more on CRON →Rockwell Automation is a pure-play automation competitor that is the successor entity to Rockwell International, which spun off its former Rockwell Collins avionics segment in 2001. As of fiscal 2021, the firm operates through three segments--intelligent devices, software and control, and lifecycle services. Intelligent devices contains its drives, sensors, and industrial components, software and control contains its information and network and security software, while lifecycle services contains its consulting and maintenance services as well as its Sensia JV with Schlumberger.
Read more on ROK →